A Proof of Concept Study into the Effects on Inhlaed Extra-Fine and Standard Formulations of Beclomethasone Dipropionate and Oral Montelukast on Surrogate Markers of Small and Large Airway Inflammation in Asthma - Small and large airway inflammation in asthma

niversity of Dundee0 个研究点目标入组 30 人开始时间: 2005年6月22日最近更新: 2017年4月3日

适应症

试验速览

暂无简介。

•Male or Female age 18-65 years old
•Ability to give informed consent
•Mild or Moderate persistent asthma
•FEV1 > 60%
•Starting dose of inhaled steroid less than 1000 microgrames of beclometasone dipropionate or equivalent
•Ability to comply with the requirements of the protocol
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Recent respiratory tract infection
•Significant concomitant respiratory disease
•Any other clinically significant medical condition that may endanger the health or safety of the participant
•Any significant laboratory result
•Use of oral corticosteroids within the last three months
•Pregnacy, planned pregnancy or lactation
•Current or ex-smokers
•Known or suspected contra-indication to any of the IMP's
•Concomitantr use of medication (including OTC medication) that may interfere with the trial

发起方

niversity of Dundee